Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose diets.

Silbernagel G, Machann J, Häring HU, Fritsche A, Peter A.

Eur J Clin Nutr. 2014 Jan;68(1):97-100. doi: 10.1038/ejcn.2013.228. Epub 2013 Nov 13.

PMID:
24219891
[PubMed - indexed for MEDLINE]
2.

Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks.

Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Keim NL, Havel PJ.

J Clin Endocrinol Metab. 2011 Dec;96(12):E2034-8. doi: 10.1210/jc.2011-1050. Epub 2011 Sep 28.

PMID:
21956423
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial.

Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, Fritsche A.

Br J Nutr. 2011 Jul;106(1):79-86. doi: 10.1017/S000711451000574X. Epub 2011 Mar 14.

PMID:
21396140
[PubMed - indexed for MEDLINE]
4.

Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).

El-Mesallamy HO, Hamdy NM, Salman TM, Mahmoud S.

Minerva Endocrinol. 2011 Sep;36(3):163-70.

PMID:
22019747
[PubMed - indexed for MEDLINE]
5.

Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.

Sokup A, Góralczyk B, Góralczyk K, Rość D.

Acta Obstet Gynecol Scand. 2012 Feb;91(2):182-8. doi: 10.1111/j.1600-0412.2011.01289.x.

PMID:
21954994
[PubMed - indexed for MEDLINE]
6.

Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans.

Silbernagel G, Lütjohann D, Machann J, Meichsner S, Kantartzis K, Schick F, Häring HU, Stefan N, Fritsche A.

Exp Diabetes Res. 2012;2012:361863. doi: 10.1155/2012/361863. Epub 2011 Nov 29.

PMID:
22203835
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.

De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD.

J Intern Med. 2005 Jan;257(1):100-9.

PMID:
15606381
[PubMed - indexed for MEDLINE]
8.

Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes.

Rezvani R, Cianflone K, McGahan JP, Berglund L, Bremer AA, Keim NL, Griffen SC, Havel PJ, Stanhope KL.

Obesity (Silver Spring). 2013 Dec;21(12):2471-80. doi: 10.1002/oby.20437. Epub 2013 Jun 13.

PMID:
23512943
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.

Tripathy D, Daniele G, Fiorentino TV, Perez-Cadena Z, Chavez-Velasquez A, Kamath S, Fanti P, Jenkinson C, Andreozzi F, Federici M, Gastaldelli A, Defronzo RA, Folli F.

Diabetologia. 2013 Oct;56(10):2153-63. doi: 10.1007/s00125-013-2976-z. Epub 2013 Jun 30.

PMID:
23811853
[PubMed - indexed for MEDLINE]
10.

A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study.

de Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, Mykkänen H, Uusitupa M.

Diabetologia. 2011 Nov;54(11):2755-67. doi: 10.1007/s00125-011-2285-3. Epub 2011 Aug 26.

PMID:
21870174
[PubMed - indexed for MEDLINE]
11.

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I.

J Nutr. 2008 Aug;138(8):1452-5.

PMID:
18641190
[PubMed - indexed for MEDLINE]
Free Article
12.

Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients.

Park JS, Cho MH, Nam JS, Ahn CW, Cha BS, Lee EJ, Lim SK, Kim KR, Lee HC.

Acta Diabetol. 2010 Jun;47(2):113-8. doi: 10.1007/s00592-009-0125-4. Epub 2009 May 5.

PMID:
19415164
[PubMed - indexed for MEDLINE]
13.

The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.

Takebayashi K, Matsumoto S, Wakabayashi S, Inukai Y, Matsutomo R, Aso Y, Inukai T.

Metabolism. 2005 Sep;54(9):1225-9.

PMID:
16125534
[PubMed - indexed for MEDLINE]
14.

Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis.

Arenillas JF, Alvarez-Sabín J, Molina CA, Chacón P, Fernández-Cadenas I, Ribó M, Delgado P, Rubiera M, Penalba A, Rovira A, Montaner J.

Stroke. 2008 May;39(5):1456-63. doi: 10.1161/STROKEAHA.107.498600. Epub 2008 Mar 6.

PMID:
18323504
[PubMed - indexed for MEDLINE]
Free Article
15.

A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Volynets V, Machann J, Küper MA, Maier IB, Spruss A, Königsrainer A, Bischoff SC, Bergheim I.

Eur J Nutr. 2013 Mar;52(2):527-35. doi: 10.1007/s00394-012-0355-z. Epub 2012 Apr 28.

PMID:
22543623
[PubMed - indexed for MEDLINE]
16.

Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.

Yajima K, Shimada A, Hirose H, Oikawa Y, Yamada S, Meguro S, Irie J, Irie S.

Clin Drug Investig. 2009;29(12):811-9. doi: 10.2165/11530610-000000000-00000.

PMID:
19888787
[PubMed - indexed for MEDLINE]
17.

Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men.

Khoo J, Piantadosi C, Duncan R, Worthley SG, Jenkins A, Noakes M, Worthley MI, Lange K, Wittert GA.

J Sex Med. 2011 Oct;8(10):2868-75. doi: 10.1111/j.1743-6109.2011.02417.x. Epub 2011 Aug 5.

PMID:
21819545
[PubMed - indexed for MEDLINE]
18.

Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study.

Navas-Carretero S, Abete I, Zulet MA, Martínez JA.

Nutr J. 2011 Jul 14;10:74. doi: 10.1186/1475-2891-10-74.

PMID:
21756320
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action?

Aljada A, Garg R, Ghanim H, Mohanty P, Hamouda W, Assian E, Dandona P.

J Clin Endocrinol Metab. 2001 Jul;86(7):3250-6.

PMID:
11443197
[PubMed - indexed for MEDLINE]
20.

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

Diabetes. 2002 Apr;51(4):1131-7.

PMID:
11916936
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk